Fuji Pharma Co (FRA:FUP) Interest Expense: €-2.1 Mil (TTM As of Mar. 2026)


FRA:FUP Fuji Pharma Co Ltd FRA:FUP
86 GF Score
Price €10.80
GF Value €9.59
! 3 Warning Signs
View Full Analysis

What is Fuji Pharma Co Interest Expense?

Fuji Pharma Co FRA:FUP +2.86% 86 Interest Expense is €-2.1 Mil as of Mar. 2026. GuruFocus rates FRA:FUP with a GF Score™ of 86/100 and a GF Value™ of €9.59. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Fuji Pharma Co's interest expense for the three months ended in Mar. 2026 was € -0.6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-2.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Fuji Pharma Co's Operating Income for the three months ended in Mar. 2026 was € 8.8 Mil. Fuji Pharma Co's Interest Expense for the three months ended in Mar. 2026 was € -0.6 Mil. Fuji Pharma Co's Interest Coverage for the quarter that ended in Mar. 2026 was 15.37. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fuji Pharma Co  (FRA:FUP) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fuji Pharma Co's Interest Expense for the three months ended in Mar. 2026 was €-0.6 Mil. Its Operating Income for the three months ended in Mar. 2026 was €8.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was €64.5 Mil.

Fuji Pharma Co's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*8.793/-0.572
=15.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Fuji Pharma Co Interest Expense Historical Data

* Premium members only.

The historical data trend for Fuji Pharma Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuji Pharma Co Interest Expense Chart

Fuji Pharma Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.41 -0.54 -0.68 -1.24 -1.90

Fuji Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.41 -0.57 -0.54 -0.46 -0.57
FRA:FUP
86GF Score
Fuji Pharma Co Ltd FRA:FUP
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuji Pharma Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of €-2.1 Mil mean?
Fuji Pharma Co (FRA:FUP) has a Interest Expense of €-2.1 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Fuji Pharma Co and its competitors.
Is Fuji Pharma Co's Interest Expense too high?
Fuji Pharma Co's current Interest Expense is €-2.1 Mil. Overall, Fuji Pharma Co has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Fuji Pharma Co's Interest Expense compare to ZTS and UTHR?
Fuji Pharma Co's Interest Expense of €-2.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Fuji Pharma Co and its competitors. Fuji Pharma Co's current Interest Expense is €-2.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuji Pharma Co stock overvalued right now?
Fuji Pharma Co (FRA:FUP) has a current Interest Expense of €-2.1 Mil. The stock's GF Value™ is €9.59, compared to a current price of €10.80 — trading 12.6% above its estimated fair value. The current Interest Expense is €-2.1 Mil. Fuji Pharma Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Fuji Pharma Co (FRA:FUP), the current Interest Expense is €-2.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuji Pharma Co (FRA:FUP) Overvalued in 2026?

Based on GuruFocus' analysis, Fuji Pharma Co stock appears to be overvalued. The current stock price of €10.80 is trading 12.6% above its estimated GF Value™ of €9.59.

Key valuation signals for FRA:FUP:

  • Interest Expense: €-2.1 Mil
  • GF Value™: €9.59 vs. price of €10.80 (12.6% above fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the FRA:FUP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fuji Pharma Co Business Description

Other Exchanges 4554:Japan
Address 5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
86GF Score

Get the complete analysis for FRA:FUP

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.80
Price
€9.59
GF Value